Study | Country Study period Study design |
Data source | Exposure definition | Non-exposure definition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
---|---|---|---|---|---|---|---|---|
Molgaard-Nielsen 2013 |
Denmark 1996 - 2011 population based cohort retrospective |
Registry-based cohort of liveborn infants in Denmark | Women who fill prescriptions for oral ketoconazole agents during the first trimester. |
unexposed (general population or NOS)
Women who did not fill prescriptions for oral azole antifungal agents during the first trimester. |
1st trimester | 72 / 968236 | Oral exposure. | |
Prescriptions for oral fluconazole that were filled by the women during pregnancy was obtained from the National Prescription Registry. |
Study | Country Study period Study design |
Data source | Case | Control | Exposition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
---|---|---|---|---|---|---|---|---|---|
Carter 2008 |
USA 1997 - 2003 case control |
National Birth Defects Prevention Study (NBDPS), USA | Cases with selected birth defects (included live births, stillbirths 20 weeks or longer or greater than 500 g, or elective terminations). | Live births without birth defects that were randomly selected from birth certificates or birth hospitals in the geographic regions monitored by the state surveillance systems. | Structured maternal interviews were conducted mainly by telephone in English or Spanish no later than 24 months after the expected date of delivery (EDD) to obtain data on maternal exposures during pregnancy. | 1st trimester | 12274 / 4774 | ||
Cases and controls were identified by the birth defects surveillance systems in 10 states of USA. Medical records were obtained for all cases and reviewed by clinical geneticists. | |||||||||
Kazy 2005 |
Hungary 1980 - 1996 case control |
Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA) | Cases with isolated and multiple congenital anomalies selected from the Hungarian Congenital Abnormality Registry. | Newborn infants without congenital abnormality. | The exposure data were obtained prospectively through antenatal care logbooks and other medical records, and retrospectively through questionnaires completed by the infants’ mothers. | 1st trimester | 22843 / 38151 | Oral ketoconazole exposure. | |
The Hungarian Congenital Abnormality Registry (HCAR), in which notification by physicians of cases with Congenital anomalies is mandatory. Controls were selected from the National Birth Registry of the Central Statistical Office. |
Risk of bias: : NA; : low; : moderate; : serious; : critical; : unclear;